CLINICAL_TRIALS
trial_result
· 2021-10-07
Clinical Trial Update: Ibudilast and Withdrawal-Related Dysphoria [Phase 2]
Summary
Phase 2 trial evaluating ibudilast for withdrawal-related dysphoria in alcohol use disorder has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, Los Angeles | Conditions: Alcohol Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2021-10-07